FUS and amyotrophic lateral sclerosis: Jacifusen is scheduled to be given to eight additional patients with FUS mutations (Figueiredo, M. (2020)—Collaboration Funds Experimental Therapy for Rare FUS-ALS, accessed 3.28.20.